Cargando…

Impact and cost-effectiveness of measles vaccination through microarray patches in 70 low-income and middle-income countries: mathematical modelling and early-stage economic evaluation

BACKGROUND: Microarray patches (MAPs) are a promising technology being developed to reduce barriers to vaccine delivery based on needles and syringes (N&S). To address the evidence gap on the public health value of applying this potential technology to immunisation programmes, we evaluated the h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, Han, Abbas, Kaja, Malvolti, Stefano, Gregory, Christopher, Ko, Melissa, Amorij, Jean-Pierre, Jit, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649680/ https://www.ncbi.nlm.nih.gov/pubmed/37949503 http://dx.doi.org/10.1136/bmjgh-2023-012204

Ejemplares similares

Exploring potential applications of measles and rubella microarray patches (MR-MAPs): use case identification
por: Malvolti, Stefano, et al.
Publicado: (2023)

Cost-effectiveness of measles and rubella elimination in low-income and middle-income countries
por: Levin, Ann, et al.
Publicado: (2023)

Estimating the future global dose demand for measles–rubella microarray patches
por: Ko, Melissa, et al.
Publicado: (2023)

Assessing the value of human papillomavirus vaccination in Gavi-eligible low-income and middle-income countries
por: Ochalek, Jessica, et al.
Publicado: (2020)

Estimates of case-fatality ratios of measles in low-income and middle-income countries: a systematic review and modelling analysis
por: Portnoy, Allison, et al.
Publicado: (2019)

Mapping routine measles vaccination in low- and middle-income countries
Publicado: (2020)

Estimating national-level measles case–fatality ratios in low-income and middle-income countries: an updated systematic review and modelling study
por: Sbarra, Alyssa N, et al.
Publicado: (2023)

Stakeholder Perceptions About Group B Streptococcus Disease and Potential for Maternal Vaccination in Low- and Middle-Income Countries
por: Mantel, Carsten, et al.
Publicado: (2021)

Comparative Distributional Impact of Routine Immunization and Supplementary Immunization Activities in Delivery of Measles Vaccine in Low- and Middle-Income Countries
por: Portnoy, Allison, et al.
Publicado: (2020)

Accelerating the Development of Measles and Rubella Microarray Patches to Eliminate Measles and Rubella: Recent Progress, Remaining Challenges
por: Hasso-Agopsowicz, Mateusz, et al.
Publicado: (2022)

Potential population-level effectiveness of one-dose HPV vaccination in low-income and middle-income countries: a mathematical modelling analysis
por: Bénard, Élodie, et al.
Publicado: (2023)

Systematic review of studies evaluating the broader economic impact of vaccination in low and middle income countries
por: Deogaonkar, Rohan, et al.
Publicado: (2012)

Impact of measles supplementary immunisation activities on utilisation of maternal and child health services in low-income and middle-income countries
por: Postolovska, Iryna, et al.
Publicado: (2018)

Incorporating Demand and Supply Constraints into Economic Evaluations in Low‐Income and Middle‐Income Countries
por: Vassall, Anna, et al.
Publicado: (2016)

Economics of physical activity in low-income and middle- income countries: a systematic review
por: Ranasinghe, Priyanga Diloshini, et al.
Publicado: (2021)

Healthcare Workers’ Preparedness: An Exploratory Study for Measles Control in a Middle-Income Country
por: El-Sokkary, Rehab H, et al.
Publicado: (2020)

The economics of physical activity in low-income and middle-income countries: protocol for a systematic review
por: Ranasinghe, Priyanga Diloshini, et al.
Publicado: (2019)

Methodological issues in economic evaluations of emergency transport systems in low-income and middle-income countries
por: Lilford, Richard, et al.
Publicado: (2021)

Comparison of Economic Evaluation Methods Across Low‐income, Middle‐income and High‐income Countries: What are the Differences and Why?
por: Griffiths, Ulla Kou, et al.
Publicado: (2016)

Integrating economic and health evidence to inform Covid-19 policy in low- and middle- income countries
por: Vassall, Anna, et al.
Publicado: (2022)

Economic Growth and Childhood Malnutrition in Low- and Middle-Income Countries
por: Büttner, Nicolas, et al.
Publicado: (2023)

Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis
por: Drolet, Mélanie, et al.
Publicado: (2021)

Geographical distribution of fertility rates in 70 low-income, lower-middle-income, and upper-middle-income countries, 2010–16: a subnational analysis of cross-sectional surveys
por: Pezzulo, Carla, et al.
Publicado: (2021)

Stakeholders’ perception on including broader economic impact of vaccines in economic evaluations in low and middle income countries: a mixed methods study
por: van der Putten, Ingeborg M, et al.
Publicado: (2015)

Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models
por: Jit, Mark, et al.
Publicado: (2011)

Economic Returns to Investment in AIDS Treatment in Low and Middle Income Countries
por: Resch, Stephen, et al.
Publicado: (2011)

Economic Costs of Childhood Lead Exposure in Low- and Middle-Income Countries
por: Attina, Teresa M., et al.
Publicado: (2013)

Economic evaluation of HCV testing approaches in low and middle income countries
por: Morgan, Jake R., et al.
Publicado: (2017)

Mathematical modelling of unemployment as the effect of COVID-19 pandemic in middle-income countries
por: Chinnadurai, K., et al.
Publicado: (2022)

Economic costs of infertility care for patients in low-income and middle-income countries: a systematic review protocol
por: Njagi, Purity, et al.
Publicado: (2020)

Methods for estimating economic benefits of surgical interventions in low-income and middle-income countries: a scoping review
por: Hilla, Amy, et al.
Publicado: (2020)

Potential benefit of extended dose schedules of human papillomavirus vaccination in the context of scarce resources and COVID-19 disruptions in low-income and middle-income countries: a mathematical modelling analysis
por: Bénard, Élodie, et al.
Publicado: (2022)

Management of neonatal jaundice in low-income and middle-income countries
por: Erdeve, Omer
Publicado: (2020)

Tackling antimicrobial resistance in low-income and middle-income countries
por: Pokharel, Sunil, et al.
Publicado: (2019)

Rotavirus vaccine protection in low-income and middle-income countries
por: Ramakrishnan, Girija, et al.
Publicado: (2019)

Improving childhood vaccination in low-income and middle-income countries
por: eBioMedicine
Publicado: (2023)

Poverty reduction and equity benefits of introducing or scaling up measles, rotavirus and pneumococcal vaccines in low-income and middle-income countries: a modelling study
por: Riumallo-Herl, Carlos, et al.
Publicado: (2018)

172: ECONOMIC BURDEN OF ROAD TRAFFIC INJURIES IN LOW AND MIDDLE INCOME COUNTRIES VERSUS HIGH INCOME COUNTRIES: A SYSTEMATIC REVIEW
por: Zakeri, Raana, et al.
Publicado: (2017)

The Clinical and Economic Burden of Colorectal Anastomotic Leaks: Middle-Income Country Perspective
por: Ribeiro Jr., Ulysses, et al.
Publicado: (2019)

Economic costs of childhood stunting to the private sector in low- and middle-income countries
por: Akseer, Nadia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pujml1i1mb20bmqaiqe10luqqp